Results 1 to 10 of about 141,118 (333)
HIV pre-exposure prophylaxis for women
Journal of Virus Eradication, 2016 Women and girls comprise nearly half of HIV-infected individuals globally and 20% of new infections in the United States, indicating an urgent need to optimise HIV prevention options in this population.
Anandi N. Sheth +2 more
doaj +4 more sources
International Journal of Preventive Medicine, 2012 Results of one study (iPrEx study) showed that a once‑daily pill containing tenofovir plus emtricitabine was safe and provided an average of 44% additional protection against HIV infection to men and transgender women who have sex with men, who were also provided with a comprehensive package of prevention services.
Ajai Kumar Singh +5 more
doaj +5 more sources
HIV moments and pre-exposure prophylaxis [PDF]
The Lancet, 2016 www.thelancet.com Vol 387 April 9, 2016 1507 Submissions should be made via our electronic submission system at http://ees.elsevier.com/ thelancet/ iPrEx trial. RMG reports non-fi nancial support from Gilead Sciences and grants from GlaxoSmithKline, outside the submitted work.
Robert M. Grant, David V. Glidden
openalex +4 more sources
Modeling HIV Pre-Exposure Prophylaxis
Frontiers in Pharmacology, 2020 Pre-exposure prophylaxis (PrEP) has emerged as a promising strategy for preventing the transmission of HIV. Although only one formulation is currently approved for PrEP, research into both new compounds and new delivery systems for PrEP regimens offer ...
Thomas Straubinger +2 more
doaj +3 more sources
Prevalence and factors associated with pre-exposure prophylaxis awareness among cisgender women of reproductive age in Burkina Faso [PDF]
Women's HealthBackground: HIV remains a global public health concern, and women continue to be disproportionately affected. Understanding the factors associated with pre-exposure prophylaxis awareness among women is crucial as an effective HIV prevention strategy ...
Michael Ekholuenetale +4 more
doaj +2 more sources
Evolving landscape of economic evaluations of HIV pre‐exposure prophylaxis and pre‐exposure prophylaxis implementation strategies: a systematic review [PDF]
Journal of the International AIDS SocietyIntroduction Economic evaluations of HIV pre‐exposure prophylaxis (PrEP) and associated implementation strategies guide evidence‐based policies, programmes and resource allocation.
Min Xi +8 more
doaj +2 more sources
Pre-exposure Prophylaxis: The Delivery Challenge [PDF]
Frontiers in Public Health, 2018 HIV pre-exposure prophylaxis (PrEP), despite its efficacy, has been slow in uptake throughout the world. This article discusses the operational and service delivery complexity, based on early real-world experience, with some recommendations on how this ...
Willem D. F. Venter
doaj +3 more sources
Pre-Exposure Prophylaxis for HIV Prevention [PDF]
North Carolina Medical Journal, 2016 Nada Fadul
openalex +3 more sources
HIV pre-exposure prophylaxis [PDF]
Canadian Medical Association Journal, 2014 Currently, PrEP refers to prophylactic daily oral use of tenofovir disoproxil fumarate/emtricitabine (TDF/FTC), a formulation that is indicated in Canada for the treatment of HIV infection.
Malika, Sharma, Darrell H S, Tan
openaire +2 more sources
Rectal pre-exposure prophylaxis (PrEP) [PDF]
Antiviral Research, 2013 Rectal pre-exposure prophylaxis (PrEP) will be a critical component of HIV prevention products due to the prevalence of unprotected receptive anal intercourse among men who have sex with men and heterosexual couples. Given the biological considerations of this compartment and the complexity of HIV infection, design of a successful rectal microbicide ...
Lisa C, Rohan, Haitao, Yang, Lin, Wang
openaire +2 more sources